DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 173 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,274,187 | +198.2% | 128,905 | +115.7% | 0.45% | +64.5% |
| Q1 2020 | $1,098,048 | +166.9% | 59,774 | +220.1% | 0.27% | +274.0% |
| Q4 2019 | $411,388 | -30.3% | 18,674 | -54.5% | 0.07% | -60.1% |
| Q3 2019 | $589,823 | -8.8% | 41,074 | 0.0% | 0.18% | +1.1% |
| Q2 2019 | $646,916 | +7.5% | 41,074 | 0.0% | 0.18% | +2.8% |
| Q1 2019 | $601,734 | +37.0% | 41,074 | 0.0% | 0.18% | -26.1% |
| Q4 2018 | $439,081 | -43.7% | 41,074 | -19.6% | 0.24% | -30.4% |
| Q3 2018 | $779,389 | -25.1% | 51,074 | -39.9% | 0.34% | -28.2% |
| Q2 2018 | $1,041,250 | – | 85,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |